Logo
S

Salubris Pharmaceuticals

447 employees

Salubris is a global integrated pharmaceutical group dedicated to the research, development, manufacture, marketing, distribution, and service of professional pharmaceutical and healthcare products to bring healthier and happier life to people worldwide through world-leading quality and innovations. Shenzhen Salubris Pharmaceuticals Co., Ltd. is a professional pharmaceutical enterprise rooted in China and devoted to improving health worldwide. The company focuses on the newest generation of innovative and specialty medicine, and is an international organization possessing and continuously developing state-of-the-art technologies and products, and has been recognized as an advanced technology enterprise and innovative high-tech company. The company has a team of high-caliber management, R&D, and marketing professionals. It has nationally approved modern GMP pharmaceutical manufacturing facilities, advanced equipment s and testing instruments, producing tablet, capsule, and injection formulations and active pharmaceutical ingredients, with subsidiary branches and marketing network throughout the country.

Investor insights

Funding rounds participated in

$261M sweet spot round size

Investor type

Public Company

Basic info

Industry

Pharmaceutical Manufacturing

Sectors

Pharmaceutical Manufacturing

Date founded

1998

Funding rounds raised

Total raised

$261M

from 1 investors over 1 rounds

S

Salubris Pharmaceuticals raised $261M on October 1, 2020

Investors: The Carlyle Group

FAQ